Khaled Y Orabi

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 7

Top Topics

Childhood Cancer

Molecular Docking

Ulcerative Colitis

Structure Activity Relationship

Top Venues

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Hanan G Sary, Mohammed A Khedr, Khaled Y Orabi
Novel Vulgarin Derivatives: Chemical Transformation, In Silico and In Vitro Studies. Molecules (Basel, Switzerland) 28 (8) (2023)
Hanan G Sary, Mohammed A Khedr, Khaled Y Orabi
Novel Vulgarin Derivatives: Chemical Transformation, In Silico and In Vitro Studies. Molecules (Basel, Switzerland) 28 (8) (2023)
Hanan G Sary, Mohammed A Khedr, Khaled Y Orabi
Novel Vulgarin Derivatives: Chemical Transformation, In Silico and In Vitro Studies. Molecules (Basel, Switzerland) 28 (8) (2023)
Hanan G Sary, Mohammed A Khedr, Khaled Y Orabi
Novel Vulgarin Derivatives: Chemical Transformation, In Silico and In Vitro Studies. Molecules (Basel, Switzerland) 28 (8) (2023)
Khaled Y Orabi, Mohamed S Abaza, Yunus A Luqmani, Rajaa Al-Attiyah
Psiadin and plectranthone selectively inhibit colorectal carcinoma cells proliferation via modulating cyclins signaling and apoptotic pathways. PloS one 16 (6) (2021)
Maitham A Khajah, Ahmed Z El-Hashim, Khaled Y Orabi, Sanaa Hawai, Hanan G Sary
Onion bulb extract can both reverse and prevent colitis in mice via inhibition of pro-inflammatory signaling molecules and neutrophil activity. PloS one 15 (10) (2020)
Dalal G Al-Adwani, Waleed M Renno, Khaled Y Orabi
Neurotherapeutic effects of Ginkgo biloba extract and its terpene trilactone, ginkgolide B, on sciatic crush injury model: A new evidence. PloS one 14 (12) (2019)